Complete report $1,850. Individual company assessments $250. The companies analyzed in this report include BASF, Cambrex, Clariant, DowPharma, DSM, Evonik, Lanxess, Lonza, Novasep, and Rhodia. For each company, the report presents: • Major joint venture, distribution, OEM and licensing partners, both industrial and academic. • Terms of collaborative agreements and specific products involved. Contains 70 pages
|